The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.1% during the 3rd quarter, Holdings Channel reports. The firm owned 9,075 shares of the medical device company’s stock after selling 105 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Cooper Companies were worth $1,001,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of COO. Vanguard Group Inc. grew its holdings in shares of Cooper Companies by 303.0% during the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after buying an additional 17,367,502 shares during the last quarter. Capital World Investors lifted its position in Cooper Companies by 301.7% during the 1st quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after acquiring an additional 4,246,519 shares during the period. Janus Henderson Group PLC lifted its position in Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after acquiring an additional 2,532,186 shares during the period. Bessemer Group Inc. grew its stake in Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after purchasing an additional 1,507,049 shares during the last quarter. Finally, Swedbank AB acquired a new position in shares of Cooper Companies in the first quarter valued at about $139,246,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Morgan Stanley lifted their target price on Cooper Companies from $95.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, September 10th. Wells Fargo & Company upped their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, August 29th. StockNews.com raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Thursday. Robert W. Baird upped their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research report on Thursday, August 29th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Trading Down 2.0 %

NASDAQ COO opened at $99.86 on Friday. The firm’s fifty day moving average is $106.97 and its two-hundred day moving average is $97.87. The Cooper Companies, Inc. has a one year low of $82.21 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The firm has a market cap of $19.89 billion, a PE ratio of 55.48, a P/E/G ratio of 2.20 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same quarter in the previous year, the firm posted $0.84 EPS. The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. Analysts expect that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the transaction, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. This represents a 78.94 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the completion of the sale, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at $520,488.54. This represents a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 256,373 shares of company stock valued at $27,637,427 over the last three months. 2.00% of the stock is currently owned by company insiders.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.